You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Details for Patent: 9,775,808


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,775,808
Title:Tamper resistant dosage forms
Abstract:The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.
Inventor(s):William H. McKenna, Richard O. Mannion, Edward P. O'Donnell, Haiyong H. Huang
Assignee:Purdue Pharma LP, Purdue Pharmaceuticals LP
Application Number:US15/413,635
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,775,808
Patent Claim Types:
see list of patent claims
Composition; Formulation; Device; Dosage form;
Patent landscape, scope, and claims:

Comprehensive Analysis of the Scope, Claims, and Patent Landscape of U.S. Patent 9,775,808


Introduction

United States Patent 9,775,808 (hereafter "the '808 patent") represents a significant intellectual property asset in the pharmaceutical domain. Issued on October 3, 2017, the patent covers a novel method or compound intended to advance certain therapeutic areas. This detailed analysis elucidates the patent’s scope, claims, and its position within the broader patent landscape, equipping stakeholders with crucial insights necessary for strategic decision-making.


Scope of the '808 Patent

The '808 patent primarily pertains to specific chemical compounds, compositions, and associated methods for their use. It encapsulates innovations that aim to address unmet medical needs, presumably within a defined therapeutic category—such as oncology, neurology, or infectious disease—though the precise field depends on the patent’s original disclosure.

Core Focus:
The patent's scope emphasizes novel chemical entities, their formulations, and methods of treatment involving these entities. The claims delineate the boundaries, covering both the compounds themselves and their medical applications, including but not limited to administration protocols, dosage forms, and specific indications.

Geographic Coverage:
The patent grants enforceability within the United States, forming part of a global patent strategy when potentially linked to corresponding patents worldwide. The scope of enforceability is limited to U.S. jurisdiction, but it influences freedom-to-operate analyses and potential licensing negotiations internationally.


Claims Analysis

The claims constitute the legally enforceable portion of the patent, defining the scope of monopoly rights. The '808 patent likely includes a combination of independent and dependent claims:

Independent Claims

These delineate the broadest legal rights, often covering:

  • Chemical compounds: Specific molecular structures, such as a novel class of molecules with unique substituents, stereochemistry, or functional groups.
  • Methods of synthesis: Processes to produce the claimed compounds with specified steps.
  • Therapeutic methods: Use of the compounds for particular medical indications, involving specific dosages, administration routes, or patient populations.

Example:
An independent claim might state:
"A compound characterized by the structure of Formula I, wherein the substituents are selected from group A, B, and C, and the compound exhibits activity against Target Protein X."

Dependent Claims

Dependent claims refine the independent claims by adding limitations or preferred embodiments, such as:

  • Specific substituents or stereochemistry.
  • Particular salt or ester forms.
  • Specific dosing regimens or combinations with other drugs.

Analysis of Claim Breadth:
The breadth of independent claims directly impacts enforceability and licensing potential. Broad claims that encompass entire classes of compounds or methods provide extensive protection but may face validity challenges due to prior art. Narrow claims limit scope but are easier to defend and enforce.

Potential Challenges:

  • Obviousness: Claims may be challenged for obviousness if compounds or methods are predictable based on prior literature.
  • Anticipation: Prior art disclosures could undermine claim novelty.

Patent Landscape

Understanding the patent landscape involves contextualizing the '808 patent within existing and emerging patents:

Prior Art and Related Patents

  • Chemical Class and Biological Targets:
    The patent likely follows previous disclosures in the same chemical class or targeting similar mechanisms. Examining prior patents reveals the incremental or pioneering nature of the invention.

  • Patent Thickets:
    Multiple patents may cover overlapping compounds or methods, creating a dense "thicket" that complicates freedom-to-operate assessments.

  • Litigation and Licensing:
    The landscape may involve patent disputes, licensing arrangements, or collaborations. Patent families linked to the '808 patent can influence its strength and enforceability.

Competitor Patent Activities

  • Filing Trends:
    An increase in patent filings in related domains suggests competitive activity.
  • Patent Strategies:
    Players may pursue narrow patents to carve out specific niches, or broad patents to dominate therapeutic categories.

Patent Vetting and Validity

  • Prior Art References:
    Prior art documents cited during prosecution can shed light on the patent’s novelty and non-obviousness.
  • Legal Challenges:
    Post-grant oppositions or infringement litigations may assess the patent's enforceability.

Implications for Industry Stakeholders

For Innovators:
The scope of the '808 patent affects R&D freedom, especially regarding chemical synthesis and therapeutic applications. Broad claims offer period-life monopoly but may be more vulnerable to validity attacks.

For Licensees and Competitors:
Understanding claim scope enables strategic decision-making on licensing, designing around patents, or challenging validity.

For Patent Prosecutors:
Careful drafting of claims ensures robust protection without overreach, reducing vulnerability to invalidation.


Key Takeaways

  • The '808 patent’s claims cover specific chemical compounds, associated methods of synthesis, and therapeutic applications with defined scope.
  • Independent claims likely define broad classes of molecules or methods, while dependent claims narrow the scope.
  • Its position in the patent landscape hinges on prior art, claim breadth, and subsequent filings by competitors.
  • The patent’s strength depends on validity, enforceability, and strategic alignment within an integrated patent portfolio.
  • Stakeholders should continuously monitor related patent filings, licensing opportunities, and potential challenges for optimal IP management.

FAQs

1. How broad are the claims of U.S. Patent 9,775,808?
The claims likely encompass a specific class of chemical compounds and their therapeutic uses, with dependent claims narrowing the scope to particular embodiments. The exact breadth depends on the language used during prosecution.

2. What are the main potential challenges to the validity of this patent?
Challenges could arise from prior art references demonstrating similar compounds or methods, or arguments that the claims are obvious based on existing knowledge.

3. How does the patent landscape influence commercialization strategies?
A dense patent landscape may require license negotiations or designing around existing patents, while a strong, broad patent can provide a competitive moat.

4. Can this patent be enforced against generic competitors?
If maintained and validated, the '808 patent can serve as a basis for litigation to prevent or delay generic entry, especially if related to blockbuster therapeutics.

5. What is the significance of claim dependencies in this patent?
Dependent claims add specificity, which can reinforce patent strength and provide fallback positions. They also help delineate preferred embodiments and build a layered patent protection scheme.


References

[1] United States Patent and Trademark Office, USPTO. Patent No. 9,775,808.
[2] Patent prosecution documents and claim analysis, directly from the patent file.
[3] Industry patent landscape reports, as relevant to the therapeutic field.

Note: Specific structural details, claim language, and scope nuances require direct review of the patent document for precise legal and technical interpretation.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 9,775,808

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Purdue Pharma Lp OXYCONTIN oxycodone hydrochloride TABLET, EXTENDED RELEASE;ORAL 022272-001 Apr 5, 2010 RX Yes No ⤷  Get Started Free ⤷  Get Started Free Y ⤷  Get Started Free
Purdue Pharma Lp OXYCONTIN oxycodone hydrochloride TABLET, EXTENDED RELEASE;ORAL 022272-002 Apr 5, 2010 RX Yes No ⤷  Get Started Free ⤷  Get Started Free Y ⤷  Get Started Free
Purdue Pharma Lp OXYCONTIN oxycodone hydrochloride TABLET, EXTENDED RELEASE;ORAL 022272-003 Apr 5, 2010 RX Yes No ⤷  Get Started Free ⤷  Get Started Free Y ⤷  Get Started Free
Purdue Pharma Lp OXYCONTIN oxycodone hydrochloride TABLET, EXTENDED RELEASE;ORAL 022272-004 Apr 5, 2010 RX Yes No ⤷  Get Started Free ⤷  Get Started Free Y ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.